What the Research Shows Record-Setting Weight Loss in Clinical Trials The SURMOUNT-1 trial [1] established Zepbound as the most effective anti-obesity medication available
EECs arise from the secretory linage, which also comprises antimicrobial peptide- producing Paneth cells (in the small intestine), Paneth-like cells (in the large intestine), mucin- producing goblet cells, serotonin-producing enterochromaffin cells, and tuft cells involved in chemosensing ( Figure 2B )
It is approved in the UK only for type 2 diabetes mellitus, though patients may experience secondary triglyceride-lowering benefits
9 Fewer triglycerides in circulation also means fewer ApoB particles, which research now identifies as the most accurate measure of cardiovascular risk from dyslipidemia (imbalance of fats in the blood)
On its official website, Refills advertises outcomes and access metrics such as "92% of patients report improved energy," "3x faster weight loss compared to lifestyle changes alone," nationwide access, and more than 10,000 personalized plans
